Other clinical factors, such as patient sex and age, histological grade, lymphatic invasion, lymph node metastasis and TNM stage, were not found to be significantly associated with ATF3 expression in this study. This evidence concerns the gene ATF3 and metastatic malignant neoplasm in the lymph nodes.